Literature DB >> 17033682

Macular degeneration: recent advances and therapeutic opportunities.

Amir Rattner1, Jeremy Nathans.   

Abstract

The central retina mediates high acuity vision, and its progressive dysfunction due to macular degeneration is the leading cause of visual disability among adults in industrialized societies. Here, we summarize recent progress in understanding the pathophysiology of macular degeneration and the implications of this new knowledge for treatment and prevention. The past decade has witnessed remarkable advances in this field, including the development of new, non-invasive retinal imaging technologies, the development of animal models for macular disease, and the isolation of many of the genes responsible for both early- and late-onset macular diseases. These advances have set the stage for the development of effective mechanism-based therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17033682     DOI: 10.1038/nrn2007

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  86 in total

1.  Reentrant spiral waves of spreading depression cause macular degeneration in hypoglycemic chicken retina.

Authors:  Yufei Yu; Laura M Santos; Linda A Mattiace; Manoel L Costa; Luciano C Ferreira; Kelly Benabou; Ana H Kim; John Abrahams; Michael V L Bennett; Renato Rozental
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.

Authors:  Fu Shang; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-10

3.  Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics).

Authors:  Tomoaki Uchiki; Karen A Weikel; Wangwang Jiao; Fu Shang; Andrea Caceres; Dorota Pawlak; James T Handa; Michael Brownlee; Ram Nagaraj; Allen Taylor
Journal:  Aging Cell       Date:  2011-11-15       Impact factor: 9.304

4.  Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells.

Authors:  Qingning Bian; Shasha Gao; Jilin Zhou; Jian Qin; Allen Taylor; Elizabeth J Johnson; Guangwen Tang; Janet R Sparrow; Dennis Gierhart; Fu Shang
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

Review 5.  Retinoids for treatment of retinal diseases.

Authors:  Krzysztof Palczewski
Journal:  Trends Pharmacol Sci       Date:  2010-06       Impact factor: 14.819

Review 6.  Age-related macular degeneration: genetic and environmental factors of disease.

Authors:  Yuhong Chen; Matthew Bedell; Kang Zhang
Journal:  Mol Interv       Date:  2010-10

7.  Ubiquitin proteasome pathway-mediated degradation of proteins: effects due to site-specific substrate deamidation.

Authors:  Edward J Dudek; Kirsten J Lampi; Jason A Lampi; Fu Shang; Jonathan King; Yongting Wang; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-30       Impact factor: 4.799

8.  Age-related neuronal loss in the cochlea is not delayed by synaptic modulation.

Authors:  David Jin; Kevin K Ohlemiller; Debin Lei; Elizabeth Dong; Lorna Role; David K Ryugo; Jianxin Bao
Journal:  Neurobiol Aging       Date:  2010-06-26       Impact factor: 4.673

9.  The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells.

Authors:  Aparna Lakkaraju; Silvia C Finnemann; Enrique Rodriguez-Boulan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

10.  The genomic response of the retinal pigment epithelium to light damage and retinal detachment.

Authors:  Amir Rattner; Leila Toulabi; John Williams; Huimin Yu; Jeremy Nathans
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.